United Arab Emirates (UAE) Blood Glucose Monitor Market Overview, 2028

The United Arab Emirates is at the forefront of healthcare innovation, particularly advances in the management of chronic illnesses such as diabetes. With an increasing emphasis on preventive healthcare, the blood glucose monitor market in the United Arab Emirates has grown and transformed significantly in recent years. The blood glucose monitor market in the United Arab Emirates is distinguished by a varied variety of offerings from both domestic and foreign manufacturers. Renowned global medical technology businesses have a strong presence in the United Arab Emirates, including cutting-edge blood glucose monitoring equipment. Local businesses have also emerged, catering to certain market niches and interests. Accessibility and affordability have been key factors in increasing the reach of blood glucose monitors throughout the United Arab Emirates. Government initiatives and healthcare policies have aimed to make these devices more accessible to patients, whether through subsidies, insurance coverage, or specialised programmes for diabetes management. Furthermore, the United Arab Emirates goal of becoming a regional medical tourism powerhouse has resulted in investments in advanced healthcare infrastructure and services. This has resulted in agreements between healthcare providers and technology businesses to bring the most up-to-date blood glucose monitoring gadgets and systems to the country, attracting patients looking for innovative healthcare solutions. The regulatory framework in the United Arab Emirates ensures that blood glucose monitoring devices fulfil stringent quality standards and follow international criteria, guaranteeing patients the products' dependability and safety. According to the research report "United Arab Emirates Blood Glucose Monitor Market Overview, 2028," published by Bonafide Research, the United Arab Emirates Blood Glucose Monitor market was valued more than USD 50 Million in 2022. The United Arab Emirates has cutting-edge healthcare facilities and a major focus on medical tourism. This infrastructure facilitates the provision of cutting-edge technologies, such as blood glucose monitoring, for residents and visitors alike. The United Arab Emirates multicultural community creates a one-of-a-kind market landscape. Manufacturers can tailor blood glucose monitoring products to varied cultural preferences, languages, and healthcare practices, ensuring market inclusion and relevance. The United Arab Emirates, ideally located in the Middle East, serves as a hub for spreading healthcare advancements throughout the region. Advances in blood glucose monitoring technology introduced in the United Arab Emirates frequently spread to neighbouring nations, influencing the larger regional market. Diabetes is a reasonably common illness in the United Arab Emirates, affecting roughly 15% of the adult population (aged 18 and above). This is due to a variety of variables, such as urbanisation, lifestyle changes, and genetic predisposition. The United Arab Emirates encourages diabetes research and innovation, with various universities and research institutions undertaking studies on new therapies, technology, and prevention techniques. Demand for user-friendly and accurate blood glucose monitoring devices is being driven by the emphasis on patient empowerment and personalised care experiences. This is consistent with the United Arab Emirates commitment to delivering patient-centred healthcare solutions. Diabetes control is part of the United Arab Emirates focus on regenerative medicine and futuristic healthcare solutions. Current research in regenerative therapeutics for diabetes has the potential to revolutionise treatment approaches, supplementing the use of blood glucose monitoring.

Based on product market is bifurcated into self-monitoring devices and continuous blood glucose monitoring devices. Continuous blood glucose monitoring devices is projected to grow at the fastest rate in United Arab Emirates blood glucose monitor market during the forecast period. Continuous glucose monitoring (CGM) devices provide continuous, real-time glucose monitoring without the need for periodic fingerstick samples. Sensor technology, accuracy, and connectivity developments have increased the appeal of CGM devices among diabetics. The United Arab Emirates government's emphasis on enhancing healthcare services and managing chronic diseases such as diabetes has fostered the use of cutting-edge technologies such as CGM devices. Subsidies, insurance coverage, or specific healthcare programmes that encourage the use of advanced diabetes management technologies have fueled CGM device expansion. With diabetes being so prevalent in the United Arab Emirates, there is a growing demand for more effective and efficient monitoring systems. CGM devices offer a proactive approach to diabetes management by providing continuous data, making them an appealing alternative for people wishing to improve their control of their condition. CGM devices frequently have wireless connectivity, allowing for seamless data transmission to smartphones or other devices. This accessibility enables individuals to discreetly and simply monitor their glucose levels, regardless of their location. As of the United Arab Emirates fast-paced lifestyle and cultural dynamics, technologies that easily fit into daily routines are preferred. CGM devices, with their low interference and continuous monitoring, are well suited to the demand for portable, on-the-go diabetes management options. Based on end user channel market is majorly segmented into hospitals, home care, and diagnostic centers. Home care end user segment is gaining significant traction in United Arab Emirates blood glucose monitor market. Home care enables diabetics to check their blood glucose levels in the privacy of their own homes, removing the need for frequent visits to healthcare institutions. This convenience is especially enticing in the United Arab Emirates, where time efficiency and convenience are highly valued. Individuals can take control of their health by actively participating in their diabetes management with home care. Home blood glucose monitors are simple to use, allowing patients to monitor their glucose levels autonomously, providing a sense of control and autonomy. The United Arab Emirates healthcare system emphasises preventive care and promotes proactive health management. Home care is consistent with this approach since it allows for frequent monitoring, early detection of glucose variations, and timely actions to prevent diabetic complications. The United Arab Emirates government's initiatives to promote healthcare at home, including subsidies for medical devices and support for telehealth services, have boosted the adoption of home care solutions, including blood glucose monitors. This support makes these devices more accessible and affordable for individuals managing diabetes. Considered in this report: • Geography: United Arab Emirates • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • United Arab Emirates Blood Glucose Monitoring Devices market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

By Product • Self-monitoring Devices • Continuous Blood Glucose Monitoring Devices By End User • Hospitals • Home Care • Diagnostic Centers By Indication • Diabetes • Pregnancy • Cardiovascular Disorders & Hypertension • Cancer • Respiratory Diseases • Movement Disorders • Hearing Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Blood Glucose Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.